A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells
Titel:
A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells
Auteur:
de Boer, Alberdina W Markowitz, Norman Lane, H.Clifford Saravolatz, Louis D Koletar, Susan L Donabedian, Haig Yoshizawa, Carl Duliege, Anne-Marie Fyfe, Gwendolyn Mitsuyasu, Ronald T